AMPICILLIN 250 mg suspension BUV

thumb
Id:
135
CisEQGAB:
0
CisGAB:
EQSEN:
368
NumGabon:
137
ATC:
J01CA01
Dci:
AMPICILLINE
Date_AMM:
30/12/2017
Fin_AMM:
30/12/2022
Titulaire:
SEDAPHARM